Cited by 246Peroxisome Proliferator-Activated ReceptorsCardiovascular Function and Risk FactorsCardiovascular Disease and Adiposity

The DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.

CD36 Deficiency Rescues Lipotoxic Cardiomyopathy

Yang, John, Sambandam, Nandakumar, Han, Xianlin, Gross, Richard W., Courtois, Michael, Kovacs, Attila, Febbraio, Maria, Finck, Brian N., Kelly, Daniel P.·2007·Circulation Research

DOI 10.1161/01.res.0000264104.25265.b6

Open this paper in CoChat — free account

Abstract

Obesity-related diabetes mellitus leads to increased myocardial uptake of fatty acids (FAs), resulting in a form of cardiac dysfunction referred to as lipotoxic cardiomyopathy. We have shown previously that chronic activation of the FA-activated nuclear receptor, peroxisome proliferator-activated receptor α (PPARα), is sufficient to drive the metabolic and functional abnormalities of the diabetic heart. Mice with cardiac-restricted overexpression of PPARα (myosin heavy chain [MHC]-PPARα) exhibit myocyte lipid accumulation and cardiac dysfunction. We sought to define the role of the long-chain FA transporter CD36 in the pathophysiology of lipotoxic forms of cardiomyopathy. MHC-PPARα mice were crossed with CD36-deficient mice (MHC-PPARα/CD36 −/− mice). The absence of CD36 prevented myocyte triacylglyceride accumulation and cardiac dysfunction in the MHC-PPARα mice under basal conditions and following administration of high-fat diet. Surprisingly, the rescue of the MHC-PPARα phenotype by CD36 deficiency was associated with increased glucose uptake and oxidation rather than changes in FA utilization. As predicted by the metabolic changes, the activation of PPARα target genes involved in myocardial FA-oxidation pathways in the hearts of the MHC-PPARα mice was unchanged in the CD36-deficient background. However, PPARα-mediated suppression of genes involved in glucose uptake and oxidation was reversed in the MHC-PPARα/ CD36 −/− mice. We conclude that CD36 is necessary for the development of lipotoxic cardiomyopathy in MHC-PPARα mice and that novel therapeutic strategies aimed at reducing CD36-mediated FA uptake show promise for the prevention or treatment of cardiac dysfunction related to obesity and diabetes.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1161/01.res.0000264104.25265.b6

Cites

57 of 57 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Diabetes, Other Risk Factors, and 12-Yr Cardiovascular Mortality for Men Screened in the Multiple Risk Factor Intervention Trial
Stamler, J., Vaccaro, O., Neaton, J. D., Wentworth, D., & The Multiple Risk Factor Intervention Trial Research Group (1993) · Diabetes Care · doi:10.2337/diacare.16.2.434 · Cited by 4,063
Peroxisome Proliferator-Activated Receptors: Nuclear Control of Metabolism
Desvergne, B., & Wahli, W. (1999) · Endocrine Reviews · doi:10.1210/edrv.20.5.0380 · Cited by 3,115
Myocardial Substrate Metabolism in the Normal and Failing Heart
Stanley, W. C., Recchia, F. A., & Lopaschuk, G. D. (2005) · Physiological Reviews · doi:10.1152/physrev.00006.2004 · Cited by 2,095
New type of cardiomyopathy associated with diabetic glomerulosclerosis
Rubler, S., Dlugash, J., Yuceoglu, Y. Z., Kumral, T., Branwood, A. W., & Grishman, A. (1972) · The American Journal of Cardiology · doi:10.1016/0002-9149(72)90595-4 · Cited by 1,835
NCEP-Defined Metabolic Syndrome, Diabetes, and Prevalence of Coronary Heart Disease Among NHANES III Participants Age 50 Years and Older
Alexander, C. M., Landsman, P. B., Teutsch, S. M., & Haffner, S. M. (2003) · Diabetes · doi:10.2337/diabetes.52.5.1210 · Cited by 1,475 · cited 1×
“Lipotoxic cardiomyopathy has been described in animal models of obesity and diabetes.15,16 In addition, humans with inborn errors in mitochondrial FA oxidation also develop cardiomyopathy associated with myocyte lipid accumulation.42 Proposed mechanisms for the development of cardiac dysfunction secondary to myocyte l…”
Background
PGC-1 coactivators: inducible regulators of energy metabolism in health and disease
Finck, B. N. (2006) · Journal of Clinical Investigation · doi:10.1172/jci27794 · Cited by 1,461
Self-citation
Lipotoxic heart disease in obese rats: Implications for human obesity
Zhou, Y.-T., Grayburn, P., Karim, A., Shimabukuro, M., Higa, M., Baetens, D., Orci, L., & Unger, R. H. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.4.1784 · Cited by 1,265
Shotgun lipidomics: Electrospray ionization mass spectrometric analysis and quantitation of cellular lipidomes directly from crude extracts of biological samples
Han, X., & Gross, R. W. (2004) · Mass Spectrometry Reviews · doi:10.1002/mas.20023 · Cited by 1,126
Self-citation
The cardiac phenotype induced by PPARα overexpression mimics that caused by diabetes mellitus
Finck, B. N., Lehman, J. J., Leone, T. C., Welch, M. J., Bennett, M. J., Kovács, A. D., Han, X., Gross, R. W., Kozak, R., Lopaschuk, G. D., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci14080 · Cited by 887
Self-citation
Expression cloning and characterization of a novel adipocyte long chain fatty acid transport protein
Schaffer, J. E., & Lodish, H. F. (1994) · Cell · doi:10.1016/0092-8674(94)90252-6 · Cited by 868

Show all 57 references

Research works printed but not linked: 3

10.1001/jama.1988.03410230074031 · DOI
10.1161/res.65.2.2526694 · DOI
10.1161/res.79.5.940 · DOI

Sorted by citations

Myocardial Fatty Acid Metabolism in Health and Disease
Lopaschuk, G. D., Ussher, J. R., Folmes, C. D. L., Jaswal, J. S., & Stanley, W. C. (2010) · Physiological Reviews · doi:10.1152/physrev.00015.2009 · Cited by 2,228
Diabetic Cardiomyopathy
Jia, G., Hill, M. A., & Sowers, J. R. (2018) · Circulation Research · doi:10.1161/circresaha.117.311586 · Cited by 1,872
Diabetic Cardiomyopathy Revisited
Boudina, S., & Abel, E. D. (2007) · Circulation · doi:10.1161/circulationaha.106.679597 · Cited by 1,543
CD36, a Scavenger Receptor Involved in Immunity, Metabolism, Angiogenesis, and Behavior
Silverstein, R. L., & Febbraio, M. (2009) · Science Signaling · doi:10.1126/scisignal.272re3 · Cited by 1,141
Self-citation
Mechanisms of diabetic cardiomyopathy and potential therapeutic strategies: preclinical and clinical evidence
Tan, Y., Zhang, Z., Zheng, C., Wintergerst, K. A., Keller, B. B., & Cai, L. (2020) · Nature Reviews Cardiology · doi:10.1038/s41569-020-0339-2 · Cited by 862
Cardiac Metabolism and its Interactions With Contraction, Growth, and Survival of Cardiomyocytes
Kolwicz, S. C., Purohit, S., & Tian, R. (2013) · Circulation Research · doi:10.1161/circresaha.113.302095 · Cited by 838
Membrane Fatty Acid Transporters as Regulators of Lipid Metabolism: Implications for Metabolic Disease
Glatz, J. F. C., Luiken, J. J. F. P., & Bonen, A. (2010) · Physiological Reviews · doi:10.1152/physrev.00003.2009 · Cited by 776
The randle cycle revisited: a new head for an old hat.
Hue, L., & Taegtmeyer, H. (2009) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00093.2009 · Cited by 743
Cardiac remodeling in obesity
Abel, E. D., Litwin, S. E., & Sweeney, G. (2008) · Physiological Reviews · doi:10.1152/physrev.00017.2007 · Cited by 736
Lipid Metabolism and Toxicity in the Heart
Goldberg, I. J., Trent, C. M., & Schulze, P. C. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.04.006 · Cited by 601
Ceramide is a cardiotoxin in lipotoxic cardiomyopathy
Park, T., Hu, Y., Noh, H. L., Drosatos, K., Okajima, K., Buchanan, J., Tuinei, J., Homma, S., Jiang, X.-C., Abel, E. D., et al. (2008) · Journal of Lipid Research · doi:10.1194/jlr.m800147-jlr200 · Cited by 425
Cellular fatty acid uptake: a pathway under construction
Su, X., & Abumrad, N. A. (2009) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2008.11.001 · Cited by 416
PPARs: diverse regulators in energy metabolism and metabolic diseases
Wang, Y.-X. (2010) · Cell Research · doi:10.1038/cr.2010.13 · Cited by 366
PGC-1 Coactivators in Cardiac Development and Disease
Rowe, G. C., Jiang, A., & Arany, Z. P. (2010) · Circulation Research · doi:10.1161/circresaha.110.223818 · Cited by 361
Lipid Use and Misuse by the Heart
Schulze, P. C., Drosatos, K., & Goldberg, I. J. (2016) · Circulation Research · doi:10.1161/circresaha.116.306842 · Cited by 367
Lipotoxicity in the heart
Wende, A. R., & Abel, E. D. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2009.09.023 · Cited by 352
Fatty acid transport across the cell membrane: Regulation by fatty acid transporters
Schwenk, R. W., Holloway, G. P., Luiken, J. J. F. P., Bonen, A., & Glatz, J. F. C. (2010) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2010.02.029 · Cited by 321
Dynamic role of the transmembrane glycoprotein CD36 (SR-B2) in cellular fatty acid uptake and utilization
Glatz, J. F. C., & Luiken, J. J. F. P. (2018) · Journal of Lipid Research · doi:10.1194/jlr.r082933 · Cited by 301
Emerging Roles of Vascular Endothelium in Metabolic Homeostasis
Pi, X., Xie, L., & Patterson, C. (2018) · Circulation Research · doi:10.1161/circresaha.118.313237 · Cited by 304
An overview of the crosstalk between inflammatory processes and metabolic dysregulation during diabetic cardiomyopathy
Palomer, X., Salvadó, L., Barroso, E., & Vázquez‐Carrera, M. (2013) · International Journal of Cardiology · doi:10.1016/j.ijcard.2013.07.150 · Cited by 290
The role of CD36 in cardiovascular disease
Shu, H., Peng, Y., Hang, W., Nie, J., Zhou, N., & Wang, D. W. (2020) · Cardiovascular Research · doi:10.1093/cvr/cvaa319 · Cited by 286
Forgotten but Not Gone
Szczepaniak, L. S., Victor, R. G., Orci, L., & Unger, R. H. (2007) · Circulation Research · doi:10.1161/circresaha.107.160457 · Cited by 260
The PPAR trio: Regulators of myocardial energy metabolism in health and disease
Madrazo, J., & Kelly, D. P. (2008) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2008.03.021 · Cited by 247
Self-citation
Cardiac contractile dysfunction in insulin-resistant rats fed a high-fat diet is associated with elevated CD36-mediated fatty acid uptake and esterification
Ouwens, D. M., Diamant, M., Fodor, M., Habets, D. D. J., Pelsers, M. M. A. L., Hasnaoui, M. E., Dang, Z., van den Brom, C. E., Vlasblom, R., Rietdijk, A., et al. (2007) · Diabetologia · doi:10.1007/s00125-007-0735-8 · Cited by 236
Recipes for Creating Animal Models of Diabetic Cardiovascular Disease
Hsueh, W. A., Abel, E. D., Breslow, J. L., Maeda, N., Davis, R. C., Fisher, E. A. A., Dansky, H. M., McClain, D. A., McIndoe, R., Wassef, M. K., et al. (2007) · Circulation Research · doi:10.1161/01.res.0000266449.37396.1f · Cited by 221
Cardiac Lipotoxicity: Molecular Pathways and Therapeutic Implications
Drosatos, K., & Schulze, P. C. (2013) · Current Heart Failure Reports · doi:10.1007/s11897-013-0133-0 · Cited by 224
Increasing Fatty Acid Oxidation Prevents High-Fat Diet–Induced Cardiomyopathy Through Regulating Parkin-Mediated Mitophagy
Shao, D., Kolwicz, S. C., Wang, P., Roe, N. D., Villet, O. M., Nishi, K., Hsu, Y. A., Flint, G. V., Caudal, A., Wang, W., et al. (2020) · Circulation · doi:10.1161/circulationaha.119.043319 · Cited by 217
Nuclear miR-320 Mediates Diabetes-Induced Cardiac Dysfunction by Activating Transcription of Fatty Acid Metabolic Genes to Cause Lipotoxicity in the Heart
Li, H., Fan, J., Zhao, Y., Zhang, X., Dai, B., Zhan, J., Yin, Z., Nie, X., Fu, X., Chen, C., et al. (2019) · Circulation Research · doi:10.1161/circresaha.119.314898 · Cited by 208
From fat to FAT (CD36/SR-B2): Understanding the regulation of cellular fatty acid uptake
Glatz, J. F. C., & Luiken, J. J. F. P. (2016) · Biochimie · doi:10.1016/j.biochi.2016.12.007 · Cited by 204
Lipid metabolism and signaling in cardiac lipotoxicity
D’Souza, K., Nzirorera, C., & Kienesberger, P. C. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2016.02.016 · Cited by 194
The VLDL receptor promotes lipotoxicity and increases mortality in mice following an acute myocardial infarction
Perman, J., Boström, P., Lindbom, M., Lidberg, U., Ståhlman, M., Hägg, D. A., Lindskog, H., Täng, M. S., Ömerovic, E., Hultén, L. M., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci43068 · Cited by 168
Lipotoxicity in obesity and diabetes-related cardiac dysfunction
Zlobine, I., Gopal, K., & Ussher, J. R. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2016.02.011 · Cited by 172
Inactivation of GSK-3β by Metallothionein Prevents Diabetes-Related Changes in Cardiac Energy Metabolism, Inflammation, Nitrosative Damage, and Remodeling
Wang, Y., Feng, W., Xue, W., Tan, Y., Hein, D. W., Li, X., & Cai, L. (2009) · Diabetes · doi:10.2337/db08-1697 · Cited by 166
Type 1 diabetic cardiomyopathy in the Akita (Ins2WT/C96Y) mouse model is characterized by lipotoxicity and diastolic dysfunction with preserved systolic function
Basu, R., Oudit, G. Y., Wang, X., Zhang, L., Ussher, J. R., Lopaschuk, G. D., & Kassiri, Z. (2009) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00452.2009 · Cited by 161
Preferential Oxidation of Triacylglyceride-Derived Fatty Acids in Heart Is Augmented by the Nuclear Receptor PPARα
Banke, N. H., Wende, A. R., Leone, T. C., O’Donnell, J. M., Abel, E. D., Kelly, D. P., & Lewandowski, E. D. (2010) · Circulation Research · doi:10.1161/circresaha.110.221713 · Cited by 160
Self-citation
PPARγ-induced cardiolipotoxicity in mice is ameliorated by PPARα deficiency despite increases in fatty acid oxidation
Son, N.-H., Yu, S., Tuinei, J., Arai, K., Hamai, H., Homma, S., Shulman, G. I., Abel, E. D., & Goldberg, I. J. (2010) · Journal of Clinical Investigation · doi:10.1172/jci40905 · Cited by 159
Taking Diabetes to Heart—Deregulation of Myocardial Lipid Metabolism in Diabetic Cardiomyopathy
Bayeva, M., Sawicki, K. T., & Ardehali, H. (2013) · Journal of the American Heart Association · doi:10.1161/jaha.113.000433 · Cited by 162
Myocardial lipid accumulation in patients with pressure-overloaded heart and metabolic syndrome
Marfella, R., Filippo, C. D., Portoghese, M., Barbieri, M., Ferraraccio, F., Siniscalchi, M., Cacciapuoti, F., Rossi, F., D’Amico, M., & Paolisso, G. (2009) · Journal of Lipid Research · doi:10.1194/jlr.p900032-jlr200 · Cited by 151
Opposite Regulation of CD36 Ubiquitination by Fatty Acids and Insulin
Smith, J., Su, X., El-Maghrabi, R. M., Stahl, P. D., & Abumrad, N. A. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m800008200 · Cited by 152
Insulin-stimulated cardiac glucose oxidation is increased in high-fat diet-induced obese mice lacking malonyl CoA decarboxylase
Ussher, J. R., Koves, T. R., Jaswal, J. S., Zhang, L., Ilkayeva, O., Dyck, J. R. B., Muoio, D. M., & Lopaschuk, G. D. (2009) · Diabetes · doi:10.2337/db09-0011 · Cited by 135
CD36 Expression Contributes to Age-Induced Cardiomyopathy in Mice
Koonen, D. P. Y., Febbraio, M., Bonnet, S., Nagendran, J., Young, M. E., Michelakis, E. D., & Dyck, J. R. B. (2007) · Circulation · doi:10.1161/circulationaha.107.712901 · Cited by 137
Self-citation
Endothelial Cell Receptors in Tissue Lipid Uptake and Metabolism
Abumrad, N. A., Cabodevilla, A. G., Samovski, D., Pietka, T., Basu, D., & Goldberg, I. J. (2021) · Circulation Research · doi:10.1161/circresaha.120.318003 · Cited by 127
CD36 as a gatekeeper of myocardial lipid metabolism and therapeutic target for metabolic disease
Glatz, J. F. C., Heather, L. C., & Luiken, J. J. F. P. (2023) · Physiological Reviews · doi:10.1152/physrev.00011.2023 · Cited by 134
CD36-dependent Regulation of Muscle FoxO1 and PDK4 in the PPARδ/β-mediated Adaptation to Metabolic Stress
Nahlé, Z., Hsieh, M., Pietka, T., Coburn, C. T., Grimaldi, P. A., Zhang, M. Q., Das, D., & Abumrad, N. A. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m706478200 · Cited by 122
Adaptation and maladaptation of the heart in obesity
Harmancey, R., Wilson, C. R., & Taegtmeyer, H. (2008) · Hypertension · doi:10.1161/hypertensionaha.108.110031 · Cited by 121
Rescue of Cardiomyopathy in Peroxisome Proliferator-Activated Receptor-α Transgenic Mice by Deletion of Lipoprotein Lipase Identifies Sources of Cardiac Lipids and Peroxisome Proliferator-Activated Receptor-α Activators
Duncan, J. G., Bharadwaj, K. G., Fong, J. L., Mitra, R., Sambandam, N., COURTOIS, M. R., Lavine, K. J., Goldberg, I. J., & Kelly, D. P. (2010) · Circulation · doi:10.1161/circulationaha.109.888735 · Cited by 126
Self-citation
Chylomicron- and VLDL-derived Lipids Enter the Heart through Different Pathways
Bharadwaj, K. G., Hiyama, Y., Hu, Y., Huggins, L. A., Ramakrishnan, R., Abumrad, N. A., Shulman, G. I., Blaner, W. S., & Goldberg, I. J. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.174458 · Cited by 122
Fatty acids and evolving roles of their proteins in neurological, cardiovascular disorders and cancers
Mallick, R., Basak, S., & Duttaroy, A. K. (2021) · Progress in Lipid Research · doi:10.1016/j.plipres.2021.101116 · Cited by 126
Obesity-induced dysregulation of skin-resident PPARγ+ Treg cells promotes IL-17A-mediated psoriatic inflammation
Sivasami, P., Elkins, C. M., Diaz-Saldana, P. P., Goss, K. L., Peng, A. C.-Y., Hamersky, M., Bae, J., Xu, M., Pollack, B. P., Horwitz, E. M., et al. (2023) · Immunity · doi:10.1016/j.immuni.2023.06.021 · Cited by 118
Chronic Inhibition of Pyruvate Dehydrogenase in Heart Triggers an Adaptive Metabolic Response
Chambers, K. T., Leone, T. C., Sambandam, N., Kovács, A. D., Wagg, C. S., Lopaschuk, G. D., Finck, B. N., & Kelly, D. P. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.217349 · Cited by 109
Self-citation
Fatty Acid Metabolism in Pulmonary Arterial Hypertension: Role in Right Ventricular Dysfunction and Hypertrophy
Talati, M. H., & Hemnes, A. R. (2015) · Pulmonary Circulation · doi:10.1086/681227 · Cited by 106
Mechanisms of Lipid Accumulation in the Bone Morphogenetic Protein Receptor Type 2 Mutant Right Ventricle
Talati, M. H., Brittain, E. L., Fessel, J. P., Penner, N. L., Atkinson, J. R., Funke, M., Grueter, C. A., Jerome, W. G., Freeman, M. L., Newman, J. H., et al. (2016) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201507-1444oc · Cited by 108
CD36 actions in the heart: Lipids, calcium, inflammation, repair and more?
Abumrad, N. A., & Goldberg, I. J. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2016.03.015 · Cited by 109
Deranged Myocardial Fatty Acid Metabolism in Heart Failure
Yamamoto, T., & Sano, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23020996 · Cited by 107
CD36 inhibition prevents lipid accumulation and contractile dysfunction in rat cardiomyocytes
Angın, Y., Steinbusch, L. K. M., Simons, P. J., Greulich, S., Hoebers, N., Douma, K., van Zandvoort, M. A. M. J., Coumans, W. A., Wijnen, W. J., Diamant, M., et al. (2012) · Biochemical Journal · doi:10.1042/bj20120060 · Cited by 101
Glucagon‐like peptide‐1 ameliorates cardiac lipotoxicity in diabetic cardiomyopathy via the PPAR α pathway
Wu, L., Wang, K., Wang, W., Zheng, W., Wang, P., Liu, L., & Wang, D. W. (2018) · Aging Cell · doi:10.1111/acel.12763 · Cited by 94
Re-balancing cellular energy substrate metabolism to mend the failing heart
Glatz, J. F. C., Nabben, M., Young, M. E., Schulze, P. C., Taegtmeyer, H., & Luiken, J. J. F. P. (2019) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2019.165579 · Cited by 93
High fat diet induced diabetic cardiomyopathy
Dirkx, E., Schwenk, R. W., Glatz, J. F. C., Luiken, J. J. F. P., & van Eys, G. J. J. M. (2011) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2011.04.018 · Cited by 93
Perturbations in the gene regulatory pathways controlling mitochondrial energy production in the failing heart
Aubert, G., Vega, R. B., & Kelly, D. P. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2012.08.015 · Cited by 93
Self-citation
The role of CD36 in the regulation of myocardial lipid metabolism
Kim, T. T., & Dyck, J. R. B. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2016.03.018 · Cited by 91
The Mitochondria in Diabetic Heart Failure: From Pathogenesis to Therapeutic Promise
Schilling, J. D. (2015) · Antioxidants and Redox Signaling · doi:10.1089/ars.2015.6294 · Cited by 90
Metabolic remodeling in hypertrophied and failing myocardium: a review
Peterzan, M. A., Lygate, C. A., Neubauer, S., & Rider, O. J. (2017) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00731.2016 · Cited by 88
The Multifunctionality of CD36 in Diabetes Mellitus and Its Complications—Update in Pathogenesis, Treatment and Monitoring
Puchałowicz, K., & Rać, M. E. (2020) · Cells · doi:10.3390/cells9081877 · Cited by 88
The Implication of PGC-1α on Fatty Acid Transport across Plasma and Mitochondrial Membranes in the Insulin Sensitive Tissues
Supruniuk, E., Mikłosz, A., & Chabowski, A. (2017) · Frontiers in Physiology · doi:10.3389/fphys.2017.00923 · Cited by 81
Endothelial cell–cardiomyocyte crosstalk in diabetic cardiomyopathy
Wan, A., & Rodrigues, B. B. (2016) · Cardiovascular Research · doi:10.1093/cvr/cvw159 · Cited by 85
Loss of stearoyl-CoA desaturase 1 inhibits fatty acid oxidation and increases glucose utilization in the heart
Dobrzyń, P., Sampath, H., Dobrzyń, A., Miyazaki, M., & Ntambi, J. M. (2007) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00471.2007 · Cited by 82
The PPARα‐PGC‐1α Axis Controls Cardiac Energy Metabolism in Healthy and Diseased Myocardium
Duncan, J. G., & Finck, B. N. (2007) · PPAR Research · doi:10.1155/2008/253817 · Cited by 87
Self-citation
Inhibition of sarcolemmal FAT/CD36 by sulfo-N-succinimidyl oleate rapidly corrects metabolism and restores function in the diabetic heart following hypoxia/reoxygenation
Mansor, L. S., Fialho, M. D. L. S., Yea, G., Coumans, W. A., West, J. A., Kerr, M. J., Carr, C. A., Luiken, J. J. F. P., Glatz, J. F. C., Evans, R. D., et al. (2017) · Cardiovascular Research · doi:10.1093/cvr/cvx045 · Cited by 80
The Pathophysiological Basis of Diabetic Cardiomyopathy Development
Арманович, А. А., Popov, S. V., & Shalnova, S. A. (2022) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2022.101156 · Cited by 79
Glucocorticoids and cyclic AMP selectively increase hepatic lipin-1 expression, and insulin acts antagonistically
Manmontri, B., Sarıahmetoğlu, M., Donkor, J., Khalil, M. B., Sundaram, M., Yao, Z., Reue, K., Lehner, R. S., & Brindley, D. N. (2008) · Journal of Lipid Research · doi:10.1194/jlr.m800013-jlr200 · Cited by 76
Palmitate-Induced Vacuolar-Type H+-ATPase Inhibition Feeds Forward Into Insulin Resistance and Contractile Dysfunction
Liu, Y., Steinbusch, L. K. M., Nabben, M., Kapsokalyvas, D., van Zandvoort, M. A. M. J., Schönleitner, P., Antoons, G., Simons, P. J., Coumans, W. A., Geomini, A., et al. (2017) · Diabetes · doi:10.2337/db16-0727 · Cited by 77
Cardiomyocyte-specific ablation of CD36 improves post-ischemic functional recovery
Nagendran, J., Pulinilkunnil, T., Kienesberger, P. C., Sung, M. M. Y., Fung, D., Febbraio, M., & Dyck, J. R. B. (2013) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2013.07.020 · Cited by 78
Self-citation
Concurrent diabetes and heart failure: interplay and novel therapeutic approaches
Karwi, Q. G., Ho, K. L., Pherwani, S., Ketema, E. B., Sun, Q., & Lopaschuk, G. D. (2021) · Cardiovascular Research · doi:10.1093/cvr/cvab120 · Cited by 80
Transcriptional Control of Cardiac Fuel Metabolism and Mitochondrial FunctionPreprint
Leone, T. C., & Kelly, D. P. (2011) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2011.76.011965 · Cited by 77
Self-citation
Lipid metabolism and its implications for type 1 diabetes-associated cardiomyopathy
Ritchie, R. H., Zerenturk, E. J., Prakoso, D., & Calkin, A. C. (2017) · Journal of Molecular Endocrinology · doi:10.1530/jme-16-0249 · Cited by 73
VLDL hydrolysis by LPL activates PPAR-α through generation of unbound fatty acids
Ruby, M. A., Goldenson, B., Orasanu, G., Johnston, T. P., Plutzky, J., & Krauss, R. M. (2010) · Journal of Lipid Research · doi:10.1194/jlr.m005561 · Cited by 72
Mitochondria and Cardiac Hypertrophy.
Facundo, H. D. T. F., Brainard, R. E., Caldas, F. R. D. L., & Lucas, A. M. B. (2017) · Advances in Experimental Medicine and Biology · doi:10.1007/978-3-319-55330-6_11 · Cited by 70
Cardiac-specific adipose triglyceride lipase overexpression protects from cardiac steatosis and dilated cardiomyopathy following diet-induced obesity
Pulinilkunnil, T., Kienesberger, P. C., Nagendran, J., Sharma, N., Young, M. E., & Dyck, J. R. B. (2013) · International Journal of Obesity · doi:10.1038/ijo.2013.103 · Cited by 71
NanoSIMS Analysis of Intravascular Lipolysis and Lipid Movement across Capillaries and into Cardiomyocytes
He, C. H., Weston, T. A., Jung, R. S., Heizer, P. J., Larsson, M., Hu, X., Allan, C. M., Tontonoz, P., Reue, K., Beigneux, A. P., et al. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.03.017 · Cited by 69
Obesity accelerates cardiovascular ageing
Ruperez, C., Madeo, F., de Cabo, R., Kroemer, G., & Abdellatif, M. (2025) · European Heart Journal · doi:10.1093/eurheartj/ehaf216 · Cited by 73
Endothelial Dysfunction in Obesity and Therapeutic Targets
Engin, A. (2024) · Advances in experimental medicine and biology · doi:10.1007/978-3-031-63657-8_17 · Cited by 78
CD36 Inhibitors Reduce Postprandial Hypertriglyceridemia and Protect against Diabetic Dyslipidemia and Atherosclerosis
Géloën, A., Helin, L., Geeraert, B., Malaud, É., Holvoet, P., & Marguerie, G. A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0037633 · Cited by 67
Profile of crosstalk between glucose and lipid metabolic disturbance and diabetic cardiomyopathy: Inflammation and oxidative stress
Chen, M., Meng, X., Han, Y.-P., Yan, J.-L., Xiao, C., & Qian, L.-B. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.983713 · Cited by 66
Metabolic reprogramming via PPARα signaling in cardiac hypertrophy and failure: From metabolomics to epigenetics
Warren, J. S., Oka, S., Zablocki, D., & Sadoshima, J. (2017) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00103.2017 · Cited by 64
Changes in N6-Methyladenosine Modification Modulate Diabetic Cardiomyopathy by Reducing Myocardial Fibrosis and Myocyte Hypertrophy
Ju, W., Liu, K., Ouyang, S., Liu, Z., He, F., & Wu, J. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.702579 · Cited by 64
Cardiomyocyte Triglyceride Accumulation and Reduced Ventricular Function in Mice with Obesity Reflect Increased Long Chain Fatty Acid Uptake andDe NovoFatty Acid Synthesis
Ge, F., Hu, C., Hyodo, E., Arai, K., Zhou, S., Lobdell, H., Walewski, J. L., Homma, S., & Berk, P. D. (2011) · Journal of Obesity · doi:10.1155/2012/205648 · Cited by 64
Regulation of the subcellular trafficking of CD36, a major determinant of cardiac fatty acid utilization
Glatz, J. F. C., Nabben, M., Heather, L. C., Bonen, A., & Luiken, J. J. F. P. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2016.04.008 · Cited by 62
Increased CD36 expression in middle-aged mice contributes to obesity-related cardiac hypertrophy in the absence of cardiac dysfunction
Sung, M. M. Y., Koonen, D. P. Y., Soltys, C.-L. M., Jacobs, R. L., Febbraio, M., & Dyck, J. R. B. (2011) · Journal of Molecular Medicine · doi:10.1007/s00109-010-0720-4 · Cited by 61
Self-citation
Targeting metabolic disturbance in the diabetic heart
Fuentes‐Antrás, J., Picatoste, B., Ramírez, E., Egido, J., Tuñón, J., & Lorenzo, Ó. (2015) · Cardiovascular Diabetology · doi:10.1186/s12933-015-0173-8 · Cited by 60
Redefining Diabetic Cardiomyopathy: Perturbations in Substrate Metabolism at the Heart of Its Pathology
Heather, L. C., Gopal, K., Srnic, N., & Ussher, J. R. (2024) · Diabetes · doi:10.2337/dbi23-0019 · Cited by 59
Increased Expression of Fatty-Acid and Calcium Metabolism Genes in Failing Human Heart
García‐Rúa, V., Otero, M. F., Lear, P., Rodríguez‐Penas, D., Feijóo‐Bandín, S., Noguera-Moreno, T., Calaza, M., Álvarez‐Barredo, M., Mosquera‐Leal, A., Parrington, J., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0037505 · Cited by 59
EP 80317, a selective CD36 ligand, shows cardioprotective effects against post-ischaemic myocardial damage in mice
Bessi, V. L., Labbé, S. M., Huynh, D. N., Ménard, L., Jossart, C., Febbraio, M., Guérin, B., Bentourkia, M., Lecomte, R., Carpentier, A. C., et al. (2012) · Cardiovascular Research · doi:10.1093/cvr/cvs225 · Cited by 60
Self-citation
GCN2 deficiency ameliorates cardiac dysfunction in diabetic mice by reducing lipotoxicity and oxidative stress
Feng, W. H., Lei, T., Wang, Y., Feng, R. M., Yuan, J.-T., Shen, X., Wu, Y., Gao, J., Ding, W., & Lu, Z. (2018) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2018.10.445 · Cited by 57
Absence of fatty acid transporter CD36 protects against Western-type diet-related cardiac dysfunction following pressure overload in mice
Steinbusch, L. K. M., Luiken, J. J. F. P., Vlasblom, R., Chabowski, A., Hoebers, N., Coumans, W. A., Vroegrijk, I. O. C. M., Voshol, P. J., Ouwens, D. M., Glatz, J. F. C., et al. (2011) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00106.2011 · Cited by 57
Myocardial Metabolism in Diabetic Cardiomyopathy: Potential Therapeutic Targets
Sung, M. M. Y., Hamza, S. M., & Dyck, J. R. B. (2015) · Antioxidants and Redox Signaling · doi:10.1089/ars.2015.6305 · Cited by 57
The role of cardiac lipotoxicity in the pathogenesis of diabetic cardiomyopathy
Ussher, J. R. (2014) · Expert Review of Cardiovascular Therapy · doi:10.1586/14779072.2014.891939 · Cited by 57
SIRT6 transcriptionally regulates fatty acid transport by suppressing PPARγ
Khan, D., Ara, T., Ravi, V., Rajagopal, R., Tandon, H., Parvathy, J., Gonzalez, E. A., Asirvatham‐Jeyaraj, N., Krishna, S., Mishra, S., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109190 · Cited by 58
Understanding the distinct subcellular trafficking of CD36 and GLUT4 during the development of myocardial insulin resistance
Luiken, J. J. F. P., Nabben, M., Neumann, D., & Glatz, J. F. C. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2020.165775 · Cited by 54
Metabolic reprogramming of the heart through stearoyl-CoA desaturase
Dobrzyń, P., Bednarski, T., & Dobrzyń, A. (2014) · Progress in Lipid Research · doi:10.1016/j.plipres.2014.11.003 · Cited by 54
CD36 as a target to prevent cardiac lipotoxicity and insulin resistance
Glatz, J. F. C., Angın, Y., Steinbusch, L. K. M., Schwenk, R. W., & Luiken, J. J. F. P. (2012) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2012.04.009 · Cited by 54

Authors: Yang, J., Sambandam, N., Han, X., Gross, R. W., Courtois, M., Kovacs, A., Febbraio, M., Finck, B. N., & Kelly, D. P.
Affiliations: Cleveland Clinic (US)
From the Center for Cardiovascular Research (J.Y., N.S., R.W.G., M.C., A.K., D.P.K.) and Departments of Medicine (J.Y., N.S., X.H., R.W.G., M.C., A.K., B.N.F., D.P.K.), Molecular Biology & Pharmacology (R.W.G., D.P.K.), and Pediatrics (D.P.K.), Washington University School of Medicine, St Louis, Mo; and Department of Cell Biology (M.F.), Lerner Research Institute, Cleveland Clinic, Ohio.
ORCID: Han, Xianlin
Gross, Richard W.
Febbraio, Maria
Finck, Brian N.
Kelly, Daniel P.
Venue: Circulation Research
Publisher: Ovid Technologies (Wolters Kluwer Health)
Published: 2007-04-27
Volume: 100
Issue: 8
Pages: 1208-1217
ISSN: 0009-7330 (ISSN-L)
1524-4571
DOI: 10.1161/01.res.0000264104.25265.b6
OpenAlex: W2160476964
Cited by: 246
References: 57
Citations by year: 2026: 5 · 2025: 8 · 2024: 10 · 2023: 5 · 2022: 11 · 2021: 13 · 2020: 13 · 2019: 7 · 2018: 18 · 2017: 12 · 2016: 16 · 2015: 14 · 2014: 11 · 2013: 12 · 2012: 22
FWCI: 7.41
Type: journal article
Language: en
Open access: closed
Locations: Circulation Research (publishedVersion)
PubMed (publishedVersion)
Funders: National Heart, Lung, and Blood Institute (P01HL57278, P01HL057278, P50HL077113, K08HL076452, KO8 HL076452)
National Institute of Diabetes and Digestive and Kidney Diseases (P30 DK-52574, P30-DK56341, P30DK056341, P30DK052574)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Peroxisome Proliferator-Activated Receptors
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Function and Risk Factors
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Disease and Adiposity
Keywords: CD36, lipotoxic cardiomyopathy, PPARα, fatty acid uptake, cardiac dysfunction, triglyceride accumulation, glucose uptake, glucose oxidation, fatty acid oxidation, obesity, diabetes mellitus, myosin heavy chain, high-fat diet, myocardial lipid metabolism
MeSH terms: Animals, Diabetic Angiopathies, Fatty Acids, Glucose, Mice, Inbred C57BL, Mice, Transgenic, Obesity, Oxidation-Reduction, Phenotype, Mice, Knockout, CD36 Antigens, PPAR alpha, Adiposity, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

CD36 Deficiency Rescues Lipotoxic Cardiomyopathy

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks